The largest database of trusted experimental protocols

R9 kim 1 antibody

Manufactured by Merck Group
Sourced in United States

The R9 KIM-1 antibody is a laboratory reagent used for the detection and quantification of the kidney injury molecule-1 (KIM-1) protein in biological samples. KIM-1 is a biomarker for kidney injury and can be measured using this antibody in various research and diagnostic applications.

Automatically generated - may contain errors

2 protocols using r9 kim 1 antibody

1

Nephrotoxicity Assessment of 3D Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
k-ECM-induced 3D organoids were divided into three groups for nephrotoxicity testing: acetone (1%), cisplatin (0.2 mM) treatment, and control (without chemical reagent treatment) for 3 days, respectively. Increased expression of CYP2E1 and KIM-1 are specific signatures of nephrotoxicity. The cytotoxicity of USC organoids exposed to cisplatin or acetone was assessed using a method described in a previous study,3 (link) using immunofluorescence, as described above. Organoids were exposed to 1% acetone (Fisher, USA) or 200 μmol/L cisplatin for 3 days. Cisplatin was stored as a 200 mM stock solution in dimethyl sulfoxide (DMSO) and diluted to its final concentration in PBS/media. The cisplatin was sterile filtered using a 0.22 mm filter prior to application to the organoids. After 3 days of drug exposure, the organoids were pooled and fixed in 4% PFA. Deparaffinization and H&E staining were performed as described above. Antibodies used: secondary Alexa-488 goat-anti-mouse IgG antibody (1:1000) (Invitrogen, USA), CYP2E1 antibody (1:1000) (Millipore, USA), and R9 KIM-1 antibody (1:500) (Merck & Co, Rahway, NJ, USA). All slides were imaged using an Olympus FV1200 Laser Scanning Confocal Microscope.
+ Open protocol
+ Expand
2

Nephrotoxicity Assessment of 3D Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
k-ECM-induced 3D organoids were divided into three groups for nephrotoxicity testing: acetone (1%), cisplatin (0.2 mM) treatment, and control (without chemical reagent treatment) for 3 days, respectively. Increased expression of CYP2E1 and KIM-1 are specific signatures of nephrotoxicity. The cytotoxicity of USC organoids exposed to cisplatin or acetone was assessed using a method described in a previous study,3 (link) using immunofluorescence, as described above. Organoids were exposed to 1% acetone (Fisher, USA) or 200 μmol/L cisplatin for 3 days. Cisplatin was stored as a 200 mM stock solution in dimethyl sulfoxide (DMSO) and diluted to its final concentration in PBS/media. The cisplatin was sterile filtered using a 0.22 mm filter prior to application to the organoids. After 3 days of drug exposure, the organoids were pooled and fixed in 4% PFA. Deparaffinization and H&E staining were performed as described above. Antibodies used: secondary Alexa-488 goat-anti-mouse IgG antibody (1:1000) (Invitrogen, USA), CYP2E1 antibody (1:1000) (Millipore, USA), and R9 KIM-1 antibody (1:500) (Merck & Co, Rahway, NJ, USA). All slides were imaged using an Olympus FV1200 Laser Scanning Confocal Microscope.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!